+499.5%
MRNA vs CHYM
+38.9%
+460.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CHYM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.3% | -2.6% | -2.3% |
| 7D | +5.5% | +1.7% | +3.8% | +4.6% |
| 30D | +158.7% | +30.2% | +128.5% | +144.8% |
| 3M | +182.1% | +85.9% | +96.2% | +145.9% |
| 6M | +151.8% | +49.9% | +101.9% | +126.2% |
| YTD | +393.6% | +34.1% | +359.4% | +343.6% |
| 1Y | +499.5% | +37.0% | +462.5% | +485.4% |
| All | +499.5% | +38.9% | +460.6% | +485.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CHYM.
Daily Out/Under-Performance
Portfolio return minus CHYM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHYM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CHYM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling